Recently, immunotherapy has emerged as a promising therapy in the treatment of several solid tumors, and various immune checkpoint molecules, such as PD-1/PD-L1 and CTLA-4, have been found to play an imperial role in tumor immune escape (Chang et al., 2017). The gene discussed is PDCD1; the disease is neoplasm.